TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction

CompletedOBSERVATIONAL
Enrollment

1,218

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Actinic Keratosis
Interventions
DRUG

Ingenol mebutate

Topical field treatment as prescribed by dermatologist

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY